Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection.
David R DarleyLilibeth CarlosStefanie HennigZhixin LiuRichard DayAllan R GlanvillePublished in: European journal of clinical pharmacology (2019)
Monitoring TAC C0, HCT and CL/FHCT in patients after lung transplantation may assist clinicians in detecting patients at risk of acute rejection and may guide future research into TAC and HCT monitoring after lung transplantation.
Keyphrases
- extracorporeal membrane oxygenation
- liver failure
- respiratory failure
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- drug induced
- aortic dissection
- prognostic factors
- peritoneal dialysis
- palliative care
- acute respiratory distress syndrome
- cell cycle arrest
- intensive care unit
- hepatitis b virus
- cell death
- signaling pathway